BNP Paribas Financial Markets’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $422M | Sell |
2,217,939
-211,628
| -9% | -$36.4M | 0.15% | 112 |
|
|
2026
Q1 | $410M | Buy |
2,429,567
+296,106
| +14% | +$50.6M | 0.2% | 94 |
|
|
2025
Q4 | $360M | Buy |
2,133,461
+218,066
| +11% | +$35.4M | 0.16% | 109 |
|
|
2025
Q3 | $277M | Buy |
1,915,395
+1,451,820
| +313% | +$198M | 0.15% | 115 |
|
|
2025
Q2 | $58.6M | Sell |
463,575
-452,032
| -49% | -$55.5M | 0.03% | 511 |
|
|
2025
Q1 | $117M | Sell |
915,607
-450,165
| -33% | -$61M | 0.07% | 305 |
|
|
2024
Q4 | $181M | Sell |
1,365,772
-1,014,457
| -43% | -$143M | 0.1% | 186 |
|
|
2024
Q3 | $347M | Buy |
2,380,229
+538,899
| +29% | +$78M | 0.23% | 77 |
|
|
2024
Q2 | $253M | Sell |
1,841,330
-214,043
| -10% | -$28.6M | 0.21% | 98 |
|
|
2024
Q1 | $282M | Buy |
2,055,373
+419,903
| +26% | +$57.3M | 0.25% | 82 |
|
|
2023
Q4 | $222M | Buy |
1,635,470
+217,653
| +15% | +$26.6M | 0.25% | 72 |
|
|
2023
Q3 | $173M | Sell |
1,417,817
-59,234
| -4% | -$7.53M | 0.22% | 87 |
|
|
2023
Q2 | $188M | Buy |
1,477,051
+132,705
| +10% | +$17.2M | 0.23% | 74 |
|
|
2023
Q1 | $174M | Buy |
1,344,346
+1,073,140
| +396% | +$140M | 0.24% | 87 |
|
|
2022
Q4 | $35.6M | Sell |
271,206
-454,756
| -63% | -$58.8M | 0.05% | 432 |
|
|
2022
Q3 | $84.9M | Sell |
725,962
-196,138
| -21% | -$24.4M | 0.14% | 146 |
|
|
2022
Q2 | $108M | Sell |
922,100
-304,016
| -25% | -$36.1M | 0.17% | 131 |
|
|
2022
Q1 | $160M | Sell |
1,226,116
-56,164
| -4% | -$7.32M | 0.21% | 92 |
|
|
2021
Q4 | $196M | Sell |
1,282,280
-675,991
| -35% | -$105M | 0.28% | 67 |
|
|
2021
Q3 | $317M | Buy |
1,958,271
+153,341
| +8% | +$25.8M | 0.45% | 34 |
|
|
2021
Q2 | $295M | Buy |
1,804,930
+241,516
| +15% | +$37.2M | 0.39% | 40 |
|
|
2021
Q1 | $235M | Buy |
1,563,414
+1,523,229
| +3,791% | +$242M | 0.34% | 52 |
|
|
2020
Q4 | $6.09M | Sell |
40,185
-2,737,890
| -99% | -$391M | 0.01% | 1026 |
|
|
2020
Q3 | $376M | Sell |
2,778,075
-58,632
| -2% | -$7.95M | 0.54% | 28 |
|
|
2020
Q2 | $388M | Buy |
2,836,707
+1,849,414
| +187% | +$236M | 0.68% | 19 |
|
|
2020
Q1 | $106M | Buy |
987,293
+337,280
| +52% | +$38.8M | 0.22% | 94 |
|
|
2019
Q4 | $78.3M | Sell |
650,013
-1,408,212
| -68% | -$157M | 0.14% | 143 |
|
|
2019
Q3 | $205M | Buy |
2,058,225
+835,645
| +68% | +$87.5M | 0.36% | 57 |
|
|
2019
Q2 | $133M | Buy |
1,222,580
+459,558
| +60% | +$48.9M | 0.27% | 80 |
|
|
2019
Q1 | $85.3M | Buy |
763,022
+257,995
| +51% | +$28.3M | 0.18% | 111 |
|
|
2018
Q4 | $48.7M | Sell |
505,027
-1,430,463
| -74% | -$152M | 0.12% | 204 |
|
|
2018
Q3 | $236M | Buy |
1,935,490
+225,483
| +13% | +$26.6M | 0.35% | 52 |
|
|
2018
Q2 | $188M | Buy |
1,710,007
+305,609
| +22% | +$32.7M | 0.31% | 54 |
|
|
2018
Q1 | $150M | Buy |
1,404,398
+406,710
| +41% | +$45.1M | 0.28% | 60 |
|
|
2017
Q4 | $107M | Sell |
997,688
-596,860
| -37% | -$63.8M | 0.19% | 107 |
|
|
2017
Q3 | $177M | Buy |
1,594,548
+14,247
| +0.9% | +$1.52M | 0.43% | 45 |
|
|
2017
Q2 | $163M | Sell |
1,580,301
-909,642
| -37% | -$89.6M | 0.49% | 37 |
|
|
2017
Q1 | $243M | Buy |
2,489,943
+1,636,098
| +192% | +$157M | 0.64% | 23 |
|
|
2016
Q4 | $70.6M | Sell |
853,845
-1,900,752
| -69% | -$173M | 0.33% | 59 |
|
|
2016
Q3 | $227M | Sell |
2,754,597
-1,338,693
| -33% | -$127M | 0.93% | 17 |
|
|
2016
Q2 | $344M | Buy |
4,093,290
+1,515,729
| +59% | +$136M | 1.55% | 7 |
|
|
2016
Q1 | $212M | Sell |
2,577,561
-1,421,469
| -36% | -$127M | 0.9% | 14 |
|
|
2015
Q4 | $451M | Sell |
3,999,030
-467,229
| -10% | -$50.7M | 2.19% | 5 |
|
|
2015
Q3 | $452M | Sell |
4,466,259
-186,201
| -4% | -$22.3M | 1.13% | 8 |
|
|
2015
Q2 | $572M | Sell |
4,652,460
-460,893
| -9% | -$55.2M | 1.6% | 8 |
|
|
2015
Q1 | $585M | Buy |
5,113,353
+5,100,741
| +40,444% | +$563M | 1.62% | 8 |
|
|
2014
Q4 | $1.28M | Sell |
12,612
-10,479
| -45% | -$1.02M | ﹤0.01% | 910 |
|
|
2014
Q3 | $2.11M | Buy |
23,091
+1,212
| +6% | +$106K | ﹤0.01% | 999 |
|
|
2014
Q2 | $1.87M | Buy |
21,879
+16,290
| +291% | +$1.28M | ﹤0.01% | 978 |
|
|
2014
Q1 | $429K | Buy |
+5,589
| New | +$466K | ﹤0.01% | 1501 |
|
Other funds holding IBB
CB
BNP Paribas Financial Markets's IBB Position: Q2 2026 in Review
BNP Paribas Financial Markets reduced its iShares Biotechnology ETF (IBB) stake by 8.7% in Q2 2026, selling an estimated $36.4M and leaving 2,217,939 shares worth $422M. The position accounts for 0.15% of the portfolio, ranked #112.
BNP Paribas Financial Markets first reported a position in IBB in Q1 2014 and has held it in 50 quarters since. The position peaked at $585M in Q1 2015. 955 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- BNP Paribas Financial Markets held 2,217,939 shares of iShares Biotechnology ETF worth $422M as of Q2 2026.
- BNP Paribas Financial Markets sold 211,628 iShares Biotechnology ETF shares in Q2 2026, an estimated $36.4M.
- iShares Biotechnology ETF made up 0.15% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #112 holding.
- BNP Paribas Financial Markets first reported a position in iShares Biotechnology ETF in Q1 2014 and has held it in 50 quarters since.
- BNP Paribas Financial Markets's iShares Biotechnology ETF position peaked at $585M in Q1 2015.
- 955 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.